Weixiang He
- Topics
- Urinary Bladder and Prostate Research (8 papers)Prostate Cancer Diagnosis and Treatment (5 papers)Prostate Cancer Treatment and Research (4 papers)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Weixiang He
20 papers receiving 371 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Molecular Biology 192
- Pulmonary and Respiratory Medicine 106
- Cancer Research 69
- Urology 63
- Cell Biology 36
Countries citing papers authored by Weixiang He
This map shows the geographic impact of Weixiang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixiang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixiang He more than expected).
Fields of papers citing papers by Weixiang He
This network shows the impact of papers produced by Weixiang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixiang He. The network helps show where Weixiang He may publish in the future.
Co-authorship network of co-authors of Weixiang He
This figure shows the co-authorship network connecting the top 25 collaborators of Weixiang He. A scholar is included among the top collaborators of Weixiang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixiang He. Weixiang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Kidney function decline mediates the adverse effects of per- and poly-fluoroalkyl substances (PFAS) on uric acid levels and hyperuricemia riskbreakdown → | 38 |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 7 | |
| 7 | 27 | |
| 8 | 3 | |
| 9 | 14 | |
| 10 | 15 | |
| 11 | 6 | |
| 12 | 17 | |
| 13 | 30 | |
| 14 | 17 | |
| 15 | 6 | |
| 16 | 3 | |
| 17 | 125 | |
| 18 | 29 | |
| 19 | 6 | |
| 20 | 17 |
About Weixiang He
Weixiang He is a scholar working on Urology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 20 papers that have together received 374 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Urology (63 citations), Cancer Research (69 citations) and Pulmonary and Respiratory Medicine (106 citations). Weixiang He has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Zelin Tian, Yumin Wu, Gaosong Wu, Jianing Tang, Qian Yang, Xing Liao, Xinhua Zhang, Michael E. DiSanto, Daoquan Liu and Jianmin Liu. Their work appears in journals such as Journal of Hazardous Materials, Cancer Letters and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.